Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Sex Transm Infect ; 89(6): 460-6, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23903808

RESUMEN

OBJECTIVES: Complex interactions of vaginal microorganisms with the genital tract epithelium shape mucosal innate immunity, which holds the key to sexual and reproductive health. Bacterial vaginosis (BV), a microbiome-disturbance syndrome prevalent in reproductive-age women, occurs commonly in concert with trichomoniasis, and both are associated with increased risk of adverse reproductive outcomes and viral infections, largely attributable to inflammation. To investigate the causative relationships among inflammation, BV and trichomoniasis, we established a model of human cervicovaginal epithelial cells colonised by vaginal Lactobacillus isolates, dominant in healthy women, and common BV species (Atopobium vaginae, Gardnerella vaginalis and Prevotella bivia). METHODS: Colonised epithelia were infected with Trichomonas vaginalis (TV) or exposed to purified TV virulence factors (membrane lipophosphoglycan (LPG), its ceramide-phosphoinositol-glycan core (CPI-GC) or the endosymbiont Trichomonas vaginalis virus (TVV)), followed by assessment of bacterial colony-forming units, the mucosal anti-inflammatory microbicide secretory leucocyte protease inhibitor (SLPI), and chemokines that drive pro-inflammatory, antigen-presenting and T cells. RESULTS: TV reduced colonisation by Lactobacillus but not by BV species, which were found inside epithelial cells. TV increased interleukin (IL)-8 and suppressed SLPI, likely via LPG/CPI-GC, and upregulated IL-8 and RANTES, likely via TVV as suggested by use of purified pathogenic determinants. BV species A vaginae and G vaginalis induced IL-8 and RANTES, and also amplified the pro-inflammatory responses to both LPG/CPI-GC and TVV, whereas P bivia suppressed the TV/TVV-induced chemokines. CONCLUSIONS: These molecular host-parasite-endosymbiont-bacteria interactions explain epidemiological associations and suggest a revised paradigm for restoring vaginal immunity and preventing BV/TV-attributable inflammatory sequelae in women.


Asunto(s)
Bacterias/inmunología , Células Epiteliales/inmunología , Inmunidad Innata , Interacciones Microbianas , Trichomonas vaginalis/inmunología , Bacterias/patogenicidad , Células Cultivadas , Quimiocinas/metabolismo , Recuento de Colonia Microbiana , Células Epiteliales/microbiología , Células Epiteliales/parasitología , Femenino , Humanos , Inhibidor Secretorio de Peptidasas Leucocitarias/metabolismo , Trichomonas vaginalis/patogenicidad
2.
PLoS One ; 7(11): e48418, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23144878

RESUMEN

Wide-spread protozoan parasites carry endosymbiotic dsRNA viruses with uncharted implications to the human host. Among them, Trichomonas vaginalis, a parasite adapted to the human genitourinary tract, infects globally ∼250 million each year rendering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV infection and HPV-related cancer. While first-line antibiotic treatment (metronidazole) commonly kills the protozoan pathogen, it fails to improve reproductive outcome. We show that endosymbiotic Trichomonasvirus, highly prevalent in T. vaginalis clinical isolates, is sensed by the human epithelial cells via Toll-like receptor 3, triggering Interferon Regulating Factor -3, interferon type I and proinflammatory cascades previously implicated in preterm birth and HIV-1 susceptibility. Metronidazole treatment amplified these proinflammatory responses. Thus, a new paradigm targeting the protozoan viruses along with the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.


Asunto(s)
Antiparasitarios/farmacología , Interacciones Huésped-Patógeno/efectos de los fármacos , Parásitos/efectos de los fármacos , Parásitos/virología , Simbiosis/efectos de los fármacos , Totiviridae/efectos de los fármacos , Animales , Antibacterianos/farmacología , Femenino , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunidad Innata/efectos de los fármacos , Inflamación/patología , Factor 3 Regulador del Interferón/metabolismo , Metronidazol/farmacología , Modelos Biológicos , ARN Bicatenario/metabolismo , Ribonucleasa III/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/inmunología , Receptor Toll-Like 3/metabolismo , Trichomonas vaginalis/efectos de los fármacos , Trichomonas vaginalis/aislamiento & purificación , Trichomonas vaginalis/patogenicidad , Trichomonas vaginalis/virología , Vagina/inmunología , Vagina/parasitología , Vagina/patología , Vagina/virología , Virión/efectos de los fármacos , Virosis/inmunología , Virosis/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA